首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.
【24h】

Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.

机译:新型1,4-二取代的邻苯二嗪衍生物的合成及其抗肿瘤活性。

获取原文
获取原文并翻译 | 示例
           

摘要

In an attempt to develop potent and selective antitumor agents, a series of novel 1,4-disubstituted phthalazine derivatives was designed and synthesized. All the prepared compounds were screened for their cytotoxic activities against A549, HT-29 and MDA-MB-231 cell lines in vitro. Among them, seven compounds (7a-7e, 7j and 7i) displayed excellent selectivity for MDA-MB-231 cells with IC(50) values in the nM range, a desirable range for pharmacological testing. The most promising compound, 7a (IC(50) = 3.79 microM, 2.32 microM, 0.84 nM), was 5.6-, 10.8- and 6.9 x 10(4)- times more active than PTK-787 (IC(50) = 21.16 microM, 22.11 microM, 57.72 microM), respectively.
机译:为了开发有效的和选择性的抗肿瘤剂,设计并合成了一系列新颖的1,4-二取代的酞嗪衍生物。筛选所有制备的化合物在体外对A549,HT-29和MDA-MB-231细胞系的细胞毒活性。其中,七种化合物(7a-7e,7j和7i)对MDA-MB-231细胞具有优异的选择性,IC(50)值在nM范围内,这是药理学测试的理想范围。最有前途的化合物7a(IC(50)= 3.79 microM,2.32 microM,0.84 nM),其活性是PTK-787的5.6-,10.8-和6.9 x 10(4)-倍(IC(50)= 21.16) microM,22.11 microM,57.72 microM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号